← Back to Search

Selective Estrogen Receptor Modulator

MF101 10 grams/day for Hot Flashes

Phase 1
Waitlist Available
Led By Wulf Utian, PhD, DSc(Med), FRCOG, FACOG
Research Sponsored by Bionovo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up randomization to 4 weeks
Awards & highlights

Study Summary

This Phase 1, open label, randomized clinical trial will enroll 40 generally healthy, postmenopausal women aged 40-65 years old. Women will be randomized to one of two oral doses of MF101 for 4 weeks. Participants will be recruited at 3 clinical sites in the United States.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~randomization to 4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and randomization to 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Evaluate the safety of MF101, 10 g/day and 15 g/day
Secondary outcome measures
Compare the safety of MF101 10g/day and 15 g/day

Trial Design

2Treatment groups
Experimental Treatment
Group I: MF101 15 grams/dayExperimental Treatment1 Intervention
Group II: MF101 10 grams/dayExperimental Treatment1 Intervention

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

BionovoLead Sponsor
7 Previous Clinical Trials
1,739 Total Patients Enrolled
2 Trials studying Hot Flashes
1,380 Patients Enrolled for Hot Flashes
Wulf Utian, PhD, DSc(Med), FRCOG, FACOGPrincipal Investigator

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Clinical Trial Assessing Safety of MF101 for Hot Flushes
2011. "A Clinical Trial Assessing Safety of MF101 for Hot Flushes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01300078.
All > Flu
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top